Profile data is unavailable for this security.
About the company
MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.
- Revenue in HKD (TTM)7.43bn
- Net income in HKD-3.73bn
- Incorporated2006
- Employees8.23k
- LocationMicroport Scientific CorpNo. 1601 Zhangdong RoadZhangjiang Hi-Tech ParkSHANGHAI 201203ChinaCHN
- Phone+86 2 138954600
- Websitehttps://www.microport.com.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AK Medical Holdings Ltd | 1.18bn | 196.11m | 5.77bn | 1.05k | 29.34 | 2.24 | 19.61 | 4.90 | 0.1752 | 0.1752 | 1.05 | 2.30 | 0.3787 | 0.8406 | 2.38 | 1,119,782.00 | 6.30 | 9.27 | 7.52 | 11.28 | 61.66 | 65.06 | 16.65 | 21.78 | 2.77 | -- | 0.0431 | 22.65 | 3.97 | 12.74 | -11.07 | 4.67 | 21.67 | 5.88 |
| Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd | 350.97m | 163.19m | 6.80bn | 219.00 | 41.65 | 3.28 | 37.88 | 19.36 | 0.4706 | 0.4706 | 1.01 | 5.98 | 0.1717 | 0.5848 | 10.30 | 1,602,588.00 | 7.98 | -- | 8.25 | -- | 88.62 | -- | 46.50 | -- | 22.93 | -- | 0.0013 | -- | 31.58 | -- | 864.81 | -- | -- | -- |
| Kangji Medical Holdings Ltd | 997.26m | 542.79m | 7.18bn | 1.00k | 12.77 | 1.83 | 13.74 | 7.20 | 0.4629 | 0.4629 | 0.8504 | 3.23 | 0.2245 | 1.76 | 4.76 | 994,277.60 | 10.97 | 14.40 | 12.45 | 16.18 | 80.04 | 81.75 | 48.84 | 57.24 | 17.16 | -- | 0.011 | 49.58 | 17.76 | 21.23 | 5.28 | 28.00 | 41.50 | -- |
| LifeTech Scientific Corp | 1.36bn | 283.49m | 7.27bn | 1.45k | 24.83 | 2.00 | 38.35 | 5.33 | 0.0632 | 0.0632 | 0.3069 | 0.7839 | 0.3022 | 0.7491 | 10.46 | 943,746.00 | 2.56 | 7.09 | 3.05 | 8.51 | 78.57 | 79.66 | 8.48 | 22.69 | 2.27 | -- | 0.1459 | 0.00 | 15.48 | 17.88 | -19.09 | 16.80 | 26.11 | -- |
| Angelalign Technology Inc | 1.59bn | 57.59m | 9.96bn | 2.88k | 172.45 | 2.77 | 69.08 | 6.27 | 0.3413 | 0.3413 | 9.42 | 21.27 | 0.3194 | 5.33 | 16.70 | 551,337.60 | 1.05 | 5.76 | 1.29 | 7.59 | 62.38 | 64.33 | 3.30 | 13.98 | 4.12 | -- | 0.0188 | -- | 16.24 | 24.75 | -74.99 | -2.20 | 20.54 | -- |
| MicroPort Scientific Corp | 7.43bn | -3.73bn | 11.32bn | 8.23k | -- | 1.91 | -- | 1.52 | -2.04 | -2.04 | 4.07 | 3.23 | 0.2399 | 1.09 | 5.32 | 902,218.40 | -16.38 | -11.85 | -27.68 | -18.04 | 55.97 | 62.96 | -68.28 | -44.43 | 1.26 | -4.21 | 0.5477 | -- | 13.07 | 7.27 | -9.42 | -- | 19.44 | -- |
| Shanghai MicroPort MedBot Group Co Ltd | 112.64m | -1.09bn | 11.75bn | 650.00 | -- | 21.01 | -- | 104.34 | -1.14 | -1.14 | 0.1175 | 0.5836 | 0.0623 | 0.3746 | 42.10 | 173,289.40 | -60.96 | -- | -86.19 | -- | 14.05 | -- | -978.59 | -- | 0.8238 | -11.04 | 0.5427 | -- | 384.16 | -- | 11.20 | -- | -- | -- |
| Shanghai Haohai Biological Technology | 2.84bn | 448.13m | 14.99bn | 2.16k | 11.95 | 0.9234 | 22.82 | 5.28 | 2.63 | 2.63 | 16.64 | 34.01 | 0.3765 | 1.55 | 7.50 | 1,314,926.00 | 5.89 | 4.84 | 6.86 | 5.50 | 70.34 | 72.09 | 15.65 | 16.50 | 4.50 | -- | 0.0635 | 36.86 | 25.27 | 11.26 | 130.58 | 0.0762 | 11.96 | 14.22 |
| Holder | Shares | % Held |
|---|---|---|
| HHLR Advisors Ltd.as of 30 Jun 2023 | 153.69m | 8.38% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 34.03m | 1.86% |
| BlackRock Fund Advisorsas of 06 Jun 2024 | 9.78m | 0.53% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 7.12m | 0.39% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 6.64m | 0.36% |
| BlackRock Advisors (UK) Ltd.as of 06 Jun 2024 | 5.04m | 0.28% |
| Invesco Hong Kong Ltd.as of 29 Feb 2024 | 4.69m | 0.26% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 4.58m | 0.25% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 4.21m | 0.23% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 3.72m | 0.20% |
